Cost-effectiveness of early versus delayed disease-modifying antirheumatic drugs for psoriatic arthritis.
Overview & Synopsis
Open access biomedical research article published in Lancet Reg Health Am.
Indexed from repository: PubMed Central
(
pmc.ncbi.nlm.nih.gov)
Keyboard Shortcuts:
← / → for pages • + / - for zoom • 0 to fit width
Powered by Mozilla PDF.js v3.11
Document Information
| Document Title | Cost-effectiveness of early versus delayed disease-modifying antirheumatic drugs for psoriatic arthritis. |
|---|---|
| Author / Organization | Hundal S, Cappelli J, Haidar S, Osman M, Kaouache M, Rahme E, Goldberg SR, Gladman DD, Ringuet J, Muntyanu A, Tsoukas A, Netchiporouk E |
| Subject & Discipline | Lancet Reg Health Am |
| Categories | Medicine & Health |
| Publication Year | 2026 |
| License / Rights | Open Access / Creative Commons |
| Resource Verification | Listed PDF (Verification Pending) |
| Original Host Website |
PubMed Central
(pmc.ncbi.nlm.nih.gov)
|
| File Format | application/pdf (Portable Document Format) |
| Language | EN |
| Catalog ID | DOC-26490 |
| Original Source Link | Visit Source Page on pmc.ncbi.nlm.nih.gov » |